跳至主要内容
临床试验/CTRI/2024/06/068994
CTRI/2024/06/068994尚未招募Unknown

A Comparitive study of Oral Apremilast and Oral Minipulse Betamethasone therapy in Alopecia Areata : A Trichoscopic assessment of treatment outcomes - Nil

Dr Vaishnavi Puri0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients willing to give consent.
  • Patients of alopecia areata with more than equal to 3 patches or scalp area involving more than 10% .

排除标准

  • 1)Patients who have received topical and systemic medications for alopecia areata upto 1 month before.
  • 2) Pregnant and lactating women.
  • 3) Patients with history of active TB or incompletely treated TB.
  • 4) Patients with psychiatric illness.
  • 5) Patients with HIV, Hepatitis B and Malignancy.
  • 6) History of serious side effects to phosphodiesterase type 4 inhibitors – Apremilast.
  • 7) Patients with severe renal impairment, hepatic impairment cardiac diseases.

研究者

发起方
Dr Vaishnavi Puri

相似试验